NasdaqStockholm AB has assessed that Ortivus AB, company registration number556259-1205, fulfills Nasdaq First North Growth Market's listing requirements.
Provided that Ortivus AB, applies for admission to trading of its shares onNasdaq First North Growth Market Sweden, first day of trading is expected to beDecember 19, 2024
The company has 1,662,682 A-shares and 42,644,786 B-shares as per today's date.
Short name: |
ORTI A |
ORTI B |
Maximum Number of shares to be listed: |
1,662,682 |
42,644,786 |
ISIN code: |
SE0000188930 |
SE0000123085 |
Round Lot: |
1 |
1 |
Order book ID: |
1031 |
1032 |
Company Registration Number: |
556259-1205 |
556259-1205 |
Market segment: |
First North STO/8 |
First North STO/8 |
Tick Size table: |
MiFID II tick size table |
MiFID II tick size table |
MIC code: |
SSME |
SSME |
Trading currency: |
SEK |
SEK |
Classification
Code |
Name |
20 |
Health Care |
2010 |
Health Care |
This information is distributed at the request of the Certified Adviser,FNCA Sweden AB. For further information, please call FNCA SwedenAB on 0852800399.